[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.234.20. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 13,636
Citations 0
Viewpoint
April 30, 2019

Is It Time for Safeguards in the Adoption of Robotic Surgery?

Author Affiliations
  • 1Department of Surgery, University of Michigan, Ann Arbor
  • 2Center for Healthcare Outcomes and Policy, Ann Arbor, Michigan
JAMA. 2019;321(20):1971-1972. doi:10.1001/jama.2019.3736

On February 28, 2019, the US Food and Drug Administration (FDA) released a safety communication that cautioned patients, surgeons, and health care organizations about the use of robotic-assisted surgical systems for the management of breast cancer and other cancers.1 This safety communication cited concerns that evidence to support the use of robotic-assisted surgery for the management of these cancers was limited and may even be associated with shorter long-term survival compared with other surgical approaches.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×